Nike’s depressed valuation offers substantial five-year recovery upside, but the investment case remains hostage to wholesale repair, product innovation, margin recovery, and renewed market-share momentum.
Overview
Nike remains the world’s leading athletic-footwear and sportswear brand, operating across Nike Brand categories including running, basketball, football, training, sportswear, and Jordan, plus Converse. Its revenue is globally diversified, with approximately 56% generated internationally and 44% in the United States; product sales exceed $30 billion in footwear, $13 billion in apparel, and $2.2 billion in equipment, while channels are approximately 60% wholesale and 40% Nike Direct and Digital. **The core issue is an execution-dependent turnaround:** the earlier DTC push weakened wholesale shelf presence, enabling On, Hoka, New Balance, Adidas, and others to take share. Q4 FY2026 revenue declined 1.1% year over year to $10.97 billion, while operational EPS excluding the $0.52 IEEPA benefit was $0.20. Management now expects revenue to decline low-to-mid single digits across the next three-quarter period, although gross-margin expansion is expected to begin in Q1 FY2027. The stock trades near $40–$43, close to its 52-week low, at approximately 20.1x trailing P/E, 24.1x forward P/E, and 1.3x P/S. The investment case depends on performance-product adoption, wholesale rebuilding, World Cup marketing, and restored full-price selling.